Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,218 public trials 94 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Phase III Trial in Acute Promyelocytic Leukemia Patients

NCT00482833

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • Universitätsklinik Innsbruck Hämatologie Onkologie Innsbruck, Austria
  • Krankenhaus der Barmherzigen Schwestern Linz Linz, Austria
  • Universitätsklinik für Innere Medizin III Salzburg Salzburg, Austria
  • Klinikum Bayreuth GmbH Bayreuth, Germany
View all 110 locations
View Trial Details
Completed

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT01005368

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Kaiser Permanente Medical Office -Vandever Medical Office San Diego, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 35 locations
View Trial Details
Completed

Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720

NCT01004965

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hematologic Diseases, +4 more
Locations
  • Naval Medical Center - San Diego San Diego, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
View all 46 locations
View Trial Details
Completed

Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease

NCT02378701

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • The Johns Hopkins University Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Weill Medical College of Cornell University New York, United States
View Trial Details
Completed

Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies

NCT02795182

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • St Vincent's Hospital Darlinghurst, New South Wales, Australia
  • Concord Hospital Sydney, New South Wales, Australia
  • Royal Hobart Hospital Hobart, Tasmania, Australia
  • Monash Hospital Clayton, Victoria, Australia
View Trial Details

Related conditions